Abstract

Macrophages are a heterogeneous population of mononuclear phagocytes abundantly distributed throughout the intestinal compartments that adapt to microenvironmental specific cues. In adult mice, the majority of intestinal macrophages exhibit a mature phenotype and are derived from blood monocytes. In the steady-state, replenishment of these cells is reduced in the absence of the chemokine receptor CCR2. Within the intestine of mice with colitis, there is a marked increase in the accumulation of immature macrophages that demonstrate an inflammatory phenotype. Here, we asked whether CCR2 is necessary for the development of colitis in mice lacking the receptor for IL10. We compared the development of intestinal inflammation in mice lacking IL10RA or both IL10RA and CCR2. The absence of CCR2 interfered with the accumulation of immature macrophages in IL10R-deficient mice, including a novel population of rounded submucosal Iba1+ cells, and reduced the severity of colitis in these mice. In contrast, the absence of CCR2 did not reduce the augmented inflammatory gene expression observed in mature intestinal macrophages isolated from mice lacking IL10RA. These data suggest that both newly recruited CCR2-dependent immature macrophages and CCR2-independent residual mature macrophages contribute to the development of intestinal inflammation observed in IL10R-deficient mice.

Details

Title
CCR2 promotes monocyte recruitment and intestinal inflammation in mice lacking the interleukin-10 receptor
Author
El Sayed Shorouk 1 ; Patik Izabel 2 ; Redhu, Naresh S 3 ; Glickman, Jonathan N 4 ; Karagiannis Konstantinos 5 ; El Naenaeey El Sayed Y 6 ; Elmowalid, Gamal A 6 ; Abd El Wahab Ashraf M 6 ; Snapper, Scott B 7 ; Horwitz, Bruce H 8 

 Boston Children’s Hospital, Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438); Zagazig University, Faculty of Veterinary Medicine, Department of Microbiology, Zagazig, Egypt (GRID:grid.31451.32) (ISNI:0000 0001 2158 2757) 
 Boston Children’s Hospital, Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438) 
 Boston Children’s Hospital, Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438); Morphic Therapeutic, Waltham, USA (GRID:grid.2515.3) 
 Beth Israel Deaconess Medical Center, Department of Pathology, Boston, USA (GRID:grid.239395.7) (ISNI:0000 0000 9011 8547) 
 US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, USA (GRID:grid.417587.8) (ISNI:0000 0001 2243 3366) 
 Zagazig University, Faculty of Veterinary Medicine, Department of Microbiology, Zagazig, Egypt (GRID:grid.31451.32) (ISNI:0000 0001 2158 2757) 
 Boston Children’s Hospital, Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438); Brigham and Women’s Hospital, Division of Gastroenterology, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294) 
 Boston Children’s Hospital, Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438); Boston Children’s Hospital, Division of Emergency Medicine, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2618381094
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.